Previous 10 | Next 10 |
Gainers: Fulcrum Therapeutics (NASDAQ:FULC) +84%, Allied Healthcare Products (NASDAQ:AHPI) +39%, IMV (NASDAQ:IMV) +29%, Exagen (NASDAQ:XGN) +26%, Myomo (NYSE:MYO) +22%. Losers: SmileDirectClub (NASDAQ:SDC) -23%, EyeGate Pharmaceutica...
Final patient completed the study after more than 2 years of clinical benefits with maveropepimut-S (MVP-S) Median Overall Survival was 19.9 months, and overall survival rate was 44.9% at 23.8 months Translational analyses confirm generation of tumor-antigen directed T...
IMV (NASDAQ:IMV) announces that Frederic Ors has stepped down as CEO, effective immediately. The Board has appointed Andrew Hall, the company’s Chief Business Officer, as Interim CEO and is commencing a comprehensive search process to identify a permanent CEO. Previ...
Frederic Ors to Step Down as CEO CBO Andrew Hall Appointed Interim CEO Board Initiating Search for Permanent Successor IMV Inc. (Nasdaq:IMV; TSX:IMV) (“IMV” or the “Company”), a clinical-stage biopharmaceutical company pioneering a...
IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies against difficult-to-treat cancers, announced today that it will hold a conference call and webcast on Wednes...
IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies against difficult-to-treat cancers, today announced that members of IMV’s executive management team wi...
Gainers: Oragenics OGEN +58%, EyeGate Pharmaceuticals (EYEG) +54%, Dyadic DYAI +29%, ObsEva OBSV +27%, U.S. Physical Therapy (USPH) +15%.Losers: Infinity Pharmaceuticals INFI -30%, NanoVibronix (NAOV) -22%, ATI Physical Therapy (ATIP...
IRSA Propiedades Comerciales (IRCP) -69%.Infinity Pharmaceuticals (INFI) -23% on Q2 earnings release and updates data from bladder and breast cancer trials.TRxADE HEALTH (MEDS) -20% on Q2 earnings release.Bit Digital (BTBT) -17%.Flora Growth (FLGC) -15% to f...
Gainers: Tyme Technologies (TYME) +64%.Bit Digital (BTBT) +49%.SPAR Group (SGRP) +41%.Xenetic Biosciences (XBIO) +26%.IMV (IMV) +25%.Studio City International Holdings (MSC) +25%.Bitfarms (BITF) +24%.MicroStrategy (MSTR) +22%.Riot Blockchain (RIOT) +21%.RBC Bearings (ROLL) +19%.Losers: Iterum...
Gainers: Tyme Technologies TYME +46%, Xenetic Biosciences XBIO +40%, IMV (IMV) +18%, Translate Bio (TBIO) +10%, Reviva Pharmaceuticals (RVPH) +9%.Losers: ATI Physical Therapy ATIP -40%, Iterum Therapeutics ITRM -36%, Intec Pharm...
News, Short Squeeze, Breakout and More Instantly...
GAAP Net Income of $8.3 million or $0.25 per diluted share Non-GAAP Net Income of $11.0 million or $0.33 per diluted share Declares Third Consecutive Quarterly Dividend Immersion Corporation (NASDAQ: IMMR), a leading developer and provider of technologies for haptics, to...
IMV Inc. (the “ Company ” or “ IMV ”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX ® platform to treat solid and hematologic cancers, today announced tha...
Horizon Technology Finance Announces First Quarter 2023 Financial Results PR Newswire - First Quarter 2023 Net Investment Income per Share of $0.46 ; NAV per Share of $11.34 - - Debt Portfolio Yield of 16.3% - - Grew Portfolio Year over Year by 39% to ...